Drug Shortage Report for APO-HYDROXYUREA
| Report ID | 122276 |
| Drug Identification Number | 02247937 |
| Brand name | APO-HYDROXYUREA |
| Common or Proper name | HYDROXYUREA |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROXYUREA |
| Strength(s) | 500MG |
| Dosage form(s) | CAPSULE CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BTL |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2020-08-10 |
| Estimated end date | 2020-11-16 |
| Actual end date | 2020-11-17 |
| Shortage status | Resolved |
| Updated date | 2020-11-18 |
| Company comments | Allocating the limited inventory |
| Health Canada comments | |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.